Canada has a system of health care that is financed through taxation and public funding. As of 2024, the total per capita expenditure in Canada for health care was estimated to be about ******* Canadian dollars. This is an increase from the previous years and a significant increase from the *****, just prior to the implementation of the 1984 Canadian Health Act. The Canadian health system Canada has one of the highest health expenditures as a percentage of GDP among developed countries. The Canadian health care system is funded and administered by the provinces and territories. There are several principles that the system is founded on: public administration of the system is non-profit, plans must be comprehensive, all residents must be able to access the public health care system, health care should be accessible to anyone anywhere in Canada, and there should be few barriers to accessing healthcare. Despite the attempts at making the system equal across Canada, there are still major differences. For example, Nunavut has some of the highest per capita provincial/territorial governmental health care spending in all of Canada. Health financing in Canada Between the public and private sectors of Canada’s health system, the public sector is responsible for a majority of the health expenditures. Provincial governments are responsible for most of the health care funding, followed by direct federal funds. Drug expenditures, however, are primarily financed through private sector resources.

The amount of provincial/territorial government spending per capita in Canada is highly dependent on territory or region. It was forecasted that in 2024, Nunavut would have the highest government health expenditures per capita among all territories and provinces with some ****** Canadian dollars being spent on health care per capita. Ontario, on the other hand, had one of the lowest government health expenditures per capita forecasted for 2024 with just ***** Canadian dollars being spent per person, less than a third of Nunavut. Health spending in Canada Canada is one of the countries with the highest health expenditures globally. Other countries include the U.S., Germany, and France. Health care spending in Canada, much like the rest of the world, has been increasing. Recent data suggests that hospitals, drugs, and physicians account for the largest proportions of health care spending in Canada. Canadian medication costs Despite being one of the top health expenses in Canada, the expenditures on drugs as a percentage of the total health spending in Canada has actually decreased over time. There are several drug classes that have exceeded others in terms of spending. Tumor necrosis factor alpha inhibitors, antivirals for hepatitis C, and anti-neovascularization agents were the drug classes that accounted for the largest proportions of total public drug program spending in 2022. Alongside the increased spending in prescription drugs in Canada, non-prescription drug spending has also increased in Canada.

In 2024, the out-of-pocket health care payments in Canada were projected to come to an average of approximately ***** Canadian dollars per capita, an increase from the previous year. This statistic depicts the per capita out-of-pocket health care payments in Canada from 2010 to 2024.

This statistic shows the per capita health care spending in the United States, Canada and Germany from 2010 to 2017. In 2017, per capita health care spending in the U.S. stood at 10,209 U.S. dollars. That was more than twice as much as per capita spending in Canada.

Historical dataset showing Canada healthcare spending per capita by year from 2000 to 2023.

In 2024, it was expected that hospital expenditures in Ontario would average ******* Canadian dollars per person. This statistic depicts a forecast of the hospital expenditure per capita in Canada's provinces for 2024.

6,112 (US dollars) in 2023. Current expenditures on health per capita in current US dollars. Estimates of current health expenditures include healthcare goods and services consumed during each year.

In 2024, it was forecasted that hospital expenditures in Canada would average ***** Canadian dollars per person, which represents over a quarter of the total expenditure in healthcare per capita. Per capita health expenditures tend to differ among provinces partially due to differences in age distribution. This statistic displays a forecast of the total health expenditures per capita in Canada, by use of funds, in 2024.

In 2024, the United States had the ******* per capita health expenditure among OECD countries. At that time, per capita health expenditure in the U.S. amounted over ******** U.S. dollars, significantly higher than in Switzerland, the country with the ************** per capita health expenditure. Norway, Germany and, the Netherlands are also within the top five countries with the highest per capita health expenditure. The United States also spent the highest share of it’s gross domestic product on health care, with **** percent of its GDP spent on health care services. Health Expenditure in the U.S. The United States is the highest spending country worldwide when it comes to health care. In 2023, total health expenditure in the U.S. came close to **** trillion dollars. Expenditure as a percentage of GDP is projected to increase to approximately ** percent by the year 2033. Distribution of Health Expenditure in the U.S. Health expenditure in the United States is spread out across multiple categories such as nursing home facilities, home health care, and prescription drugs. As of 2023, the majority of health expenditure in the United States was spent on hospital care, accounting for a bit less than *** third of all health spending. Hospital care was followed by spending on physician and clinical services which accounted for ** percent of overall health expenditure.

Canada CA: Number of People Spending More Than 25% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure data was reported at 175,000.000 Person in 2010. This records an increase from the previous number of 127,000.000 Person for 2007. Canada CA: Number of People Spending More Than 25% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure data is updated yearly, averaging 110,000.000 Person from Dec 1994 (Median) to 2010, with 5 observations. The data reached an all-time high of 175,000.000 Person in 2010 and a record low of 80,000.000 Person in 1994. Canada CA: Number of People Spending More Than 25% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Canada – Table CA.World Bank.WDI: Social: Poverty and Inequality. Number of people spending more than 25% of household consumption or income on out-of-pocket health care expenditure. Out-of-pocket health expenditure is defined as any spending incurred by a household when any member uses a health good or service to receive any type of care (preventive, curative, rehabilitative, long-term or palliative care); provided by any type of provider; for any type of disease, illness or health condition; in any type of setting (outpatient, inpatient, at home).;Global Health Observatory. Geneva: World Health Organization; 2023. (https://www.who.int/data/gho/data/themes/topics/financial-protection);Sum;This indicator is related to Sustainable Development Goal 3.8.2 [https://unstats.un.org/sdgs/metadata/].

The current healthcare spending per capita in Canada was forecast to continuously increase between 2024 and 2029 by in total ******* U.S. dollars (+***** percent). After the sixth consecutive increasing year, the spending is estimated to reach ******** U.S. dollars and therefore a new peak in 2029. Depicted here is the average per capita spending, in a given country or region, with regards to healthcare. The spending refers to the average current spending of both governments and consumers per inhabitant.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to *** countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the current healthcare spending per capita in countries like Mexico and United States.

Canada CA: Number of People Spending More Than 10% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure data was reported at 899,000.000 Person in 2010. This records an increase from the previous number of 766,000.000 Person for 2007. Canada CA: Number of People Spending More Than 10% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure data is updated yearly, averaging 614,000.000 Person from Dec 1994 (Median) to 2010, with 5 observations. The data reached an all-time high of 899,000.000 Person in 2010 and a record low of 446,000.000 Person in 2000. Canada CA: Number of People Spending More Than 10% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Canada – Table CA.World Bank.WDI: Social: Poverty and Inequality. Number of people spending more than 10% of household consumption or income on out-of-pocket health care expenditure. Out-of-pocket health expenditure is defined as any spending incurred by a household when any member uses a health good or service to receive any type of care (preventive, curative, rehabilitative, long-term or palliative care); provided by any type of provider; for any type of disease, illness or health condition; in any type of setting (outpatient, inpatient, at home).;Global Health Observatory. Geneva: World Health Organization; 2023. (https://www.who.int/data/gho/data/themes/topics/financial-protection);Sum;This indicator is related to Sustainable Development Goal 3.8.2 [https://unstats.un.org/sdgs/metadata/].

Hospital Nutrition Frozen Entrees Market Outlook

According to our latest research, the Global Hospital Nutrition Frozen Entrees market size was valued at $1.8 billion in 2024 and is projected to reach $3.4 billion by 2033, expanding at a CAGR of 7.2% during the forecast period 2025–2033. One major factor driving this market’s robust growth is the increasing emphasis on patient-centric nutrition in healthcare settings, which is compelling hospitals to invest in high-quality, diverse, and specialized frozen entree options that cater to a wide range of dietary requirements and health conditions. As hospitals strive to improve patient outcomes and satisfaction, the demand for convenient, nutritionally balanced, and easily managed meal solutions is surging globally, further propelling the expansion of the hospital nutrition frozen entrees market.

Regional Outlook

North America currently holds the largest share of the global hospital nutrition frozen entrees market, accounting for over 38% of total revenue in 2024. This dominance is attributed to the region’s mature healthcare infrastructure, stringent nutritional guidelines, and a strong focus on patient well-being. The presence of leading foodservice providers and nutrition solution companies, combined with robust hospital networks, ensures widespread adoption of frozen entrees tailored for clinical settings. Additionally, regulatory initiatives by agencies such as the FDA and Health Canada to standardize hospital diets have fostered innovation and product quality. The region’s high per capita healthcare expenditure and strong awareness of specialized diets further cement North America’s leadership in the market, with hospitals increasingly opting for frozen entrees that offer convenience, safety, and consistent nutritional value.

The Asia Pacific region is the fastest-growing market, projected to expand at a CAGR of 9.5% from 2025 to 2033. Rapid urbanization, expanding healthcare infrastructure, and rising investments in hospital modernization are key drivers fueling this growth. Countries such as China, India, and Japan are witnessing a surge in hospital admissions and a growing focus on specialized nutrition, particularly for aging populations and patients with chronic diseases. The adoption of advanced food processing technologies and the entry of international players are further accelerating the uptake of hospital nutrition frozen entrees. Furthermore, government initiatives to improve healthcare quality and nutrition standards in hospitals are creating new opportunities for suppliers and manufacturers, making Asia Pacific a focal point for future market expansion.

Emerging economies in Latin America, the Middle East, and Africa are also showing promising potential, albeit at a slower pace due to infrastructural and economic constraints. In these regions, the adoption of hospital nutrition frozen entrees is primarily concentrated in urban centers and private healthcare facilities. Challenges such as limited cold chain logistics, lower healthcare spending, and varying regulatory standards can impede rapid market penetration. However, increasing awareness about the benefits of tailored nutrition in hospital settings and gradual policy reforms are expected to drive incremental growth. Localized demand for culturally relevant and affordable frozen entree options is also shaping product offerings and strategic partnerships in these emerging markets.

Report Scope

Capital and repair expenditures by type of expenditure for industry sector 62, health care and social assistance from the North American Industry Classification System (NAICS) for Canada, annual data from 1991 to 2014. (Terminated)

The objective of our study was to estimate direct healthcare costs incurred by a population-based sample of people with psychological distress or depression. We used the 2002 Canadian Community Health Survey on Mental Health and Well Being and categorized individuals as having psychological distress using the Kessler-6, major depressive disorder (MDD) using DSM-IV criteria and a comparison group of participants without MDD or psychological distress. Costs in 2013 USD were estimated by linking individuals to health administrative databases and following them until March 31, 2013. Our sample consisted of 9,965 individuals, of whom 651 and 409 had psychological distress and MDD, respectively. Although the age-and-sex adjusted per-capita costs were similarly high among the psychologically distressed ($3,364, 95% CI: $2,791, $3,937) and those with MDD ($3,210, 95% CI: $2,413, $4,008) compared to the comparison group ($2,629, 95% CI: $2,312, $2,945), the population-wide excess costs for psychological distress ($441 million) were more than twice that for MDD ($210 million) as there was a greater number of people with psychological distress than depression. We found substantial healthcare costs associated with psychological distress and depression, suggesting that psychological distress and MDD have a high cost burden and there may be public health intervention opportunities to relieve distress. Further research examining how individuals with these conditions use the healthcare system may provide insight into the allocation of limited healthcare resources while maintaining high quality care.

Medical instrument and supply manufacturers produce various nonelectric medical, dental and veterinary products for personal and professional use. The industry's broad range of medically necessary products largely shields revenue from sharp fluctuations based on changes in specific downstream market conditions. However, import pressure is an omnipresent threat that has encouraged manufacturers to embrace product innovation over standardized manufacturing. Despite these pressures, revenue for medical instrument and supply manufacturers is expected to swell at a CAGR of 3.7% to $7.0 billion through the end of 2024, including growth of 2.6% in 2024. Several large demographic and economic factors contribute to the demand for medical instruments. According to the Canadian Institute for Health Information, Canadians aged 65 and older spend significantly more per capita on healthcare than all younger demographics combined. The Canadian population aged 65 and older is growing faster than the general population, boosting overall demand for healthcare services and, in turn, medical instruments and supplies. However, the role of export markets is just as important to the industry. Exports to the United States are expected to account for more than 80.0% of all exports, so changes in US healthcare activity and currency valuations can substantially influence the industry. Recent fluctuations in export volumes since the pandemic have ultimately driven a drop in profitability across the industry. The aging Canadian population, rising healthcare expenditure and more resources dedicated to research and development will bolster revenue in the coming years. Companies will continue investing heavily in research and development to chase new niches in the expanding market while truncating foreign competition. However, import competition will remain high and efforts to promote research and development will raise costs for manufacturers, limiting the overall expansion of profit. As downstream demand climbs domestically and from crucial markets in the United States, industry revenue is expected to gain at a CAGR of 2.7% to $8.0 billion through the end of 2029.

In 2024, public sector health expenditures in Canada were estimated to increase by *** percent in comparison to 2023. While the private sector health spending is estimated to increase by *** percent in 2024 compared to the previous year. This statistic displays the annual percent change in private and public sector health expenditures in Canada from 1976 to 2022 and forecasts for the years 2023 and 2024. Public and private health expenditure in CanadaCanada’s health care system is publicly funded, however, many of its services are offered through private companies. Both private and public health expenditure in Canada have increased over the last decades. In 2021, public and private expenditures increased by *** and five percent, respectively. In Canada, physician and hospital costs are usually covered by the provincial governments; however, patients often have to pay for such services and goods like prescription drugs, dental care, and eye care by private means. There are also many private facilities offering services such as imaging, diagnostic tests, and lower-risk surgeries. In 2023, provincial governments spent an estimated *** billion Canadian dollars on health care. The Canadian Health Act was passed in 1984 by the federal government stating that all citizens would have an universally accessible and comprehensive health care. While public per capita health expenditure in Canada wasn't the highest compared to other OECD countries, its private per capita health spending was the second highest in the American continent after the United States in 2022. Around ** percent of health expenditures are considered public, and the rest is considered private in Canada.

Canada CA: Number of People Pushed Below the 50% Median Consumption Poverty Line by Out-of-Pocket Health Care Expenditure data was reported at 310,000.000 Person in 2010. This records an increase from the previous number of 254,000.000 Person for 2007. Canada CA: Number of People Pushed Below the 50% Median Consumption Poverty Line by Out-of-Pocket Health Care Expenditure data is updated yearly, averaging 205,000.000 Person from Dec 1994 (Median) to 2010, with 5 observations. The data reached an all-time high of 310,000.000 Person in 2010 and a record low of 137,000.000 Person in 2000. Canada CA: Number of People Pushed Below the 50% Median Consumption Poverty Line by Out-of-Pocket Health Care Expenditure data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Canada – Table CA.World Bank.WDI: Social: Poverty and Inequality. Number of people pushed below the 50% median consumption poverty line by out-of-pocket health care expenditure; ; Wagstaff et al. Progress on Impoverishing Health Spending: Results for 122 Countries. A Retrospective Observational Study, Lancet Global Health 2017; Sum;

BackgroundAcute gastrointestinal illness (AGI) incidence and per-capita healthcare expenditures are higher in some Inuit communities as compared to elsewhere in Canada. Consequently, there is a demand for strategies that will reduce the individual-level costs of AGI; this will require a comprehensive understanding of the economic costs of AGI. However, given Inuit communities’ unique cultural, economic, and geographic contexts, there is a knowledge gap regarding the context-specific indirect costs of AGI borne by Inuit community members. This study aimed to identify the major indirect costs of AGI, and explore factors associated with these indirect costs, in the Inuit community of Rigolet, Canada, in order to develop a case-based context-specific study framework that can be used to evaluate these costs.MethodsA mixed methods study design and community-based methods were used. Qualitative in-depth, group, and case interviews were analyzed using thematic analysis to identify and describe indirect costs of AGI specific to Rigolet. Data from two quantitative cross-sectional retrospective surveys were analyzed using univariable regression models to examine potential associations between predictor variables and the indirect costs.Results/SignificanceThe most notable indirect costs of AGI that should be incorporated into cost-of-illness evaluations were the tangible costs related to missing paid employment and subsistence activities, as well as the intangible costs associated with missing community and cultural events. Seasonal cost variations should also be considered. This study was intended to inform cost-of-illness studies conducted in Rigolet and other similar research settings. These results contribute to a better understanding of the economic impacts of AGI on Rigolet residents, which could be used to help identify priority areas and resource allocation for public health policies and programs.

PETG Medical Blister Market Outlook

According to our latest research, the PETG Medical Blister market size was valued at $1.8 billion in 2024 and is projected to reach $3.4 billion by 2033, expanding at a robust CAGR of 7.2% during the forecast period of 2025–2033. The primary factor fueling the global growth of the PETG Medical Blister market is the increasing demand for safe, durable, and sustainable packaging solutions in the healthcare sector. PETG (polyethylene terephthalate glycol) blisters offer superior clarity, chemical resistance, and formability, making them the preferred choice for pharmaceutical, medical device, and diagnostic packaging. The ongoing shift toward patient safety, stringent regulatory requirements, and the rising adoption of innovative medical devices are further propelling market expansion on a global scale.

Regional Outlook

North America currently holds the largest share in the PETG Medical Blister market, accounting for approximately 38% of the global revenue in 2024. This dominance can be attributed to the region's mature healthcare infrastructure, high healthcare expenditure, and early adoption of advanced packaging technologies. The presence of leading pharmaceutical companies and medical device manufacturers in the United States and Canada further strengthens the demand for PETG blister packaging. Stringent regulations imposed by the FDA and Health Canada regarding pharmaceutical and medical device packaging drive continuous innovation and quality improvements. Additionally, the region benefits from a well-established supply chain, robust R&D investments, and a strong focus on sustainability, positioning North America as the benchmark for global PETG medical blister adoption.

The Asia Pacific region is poised to be the fastest-growing market for PETG Medical Blister during the forecast period, with an impressive CAGR of 9.4% from 2025 to 2033. This growth is primarily driven by rapid urbanization, expanding healthcare access, and significant investments in pharmaceutical manufacturing across countries such as China, India, and Japan. The proliferation of hospitals, clinics, and diagnostic centers, coupled with rising awareness about the importance of safe and tamper-evident packaging, is accelerating market demand. Government initiatives aimed at strengthening local pharmaceutical production and export capabilities are also fueling the adoption of PETG blister solutions. Moreover, the region's cost-competitive manufacturing landscape and increasing foreign direct investment are attracting global players to establish production bases in Asia Pacific.

Emerging economies in Latin America, the Middle East, and Africa are witnessing a gradual increase in the adoption of PETG Medical Blister packaging, although the market share remains relatively modest compared to developed regions. These markets face challenges such as limited healthcare infrastructure, lower per capita healthcare spending, and fluctuating regulatory frameworks. However, localized demand for affordable and reliable medical packaging is rising, particularly in urban centers and private healthcare facilities. International aid programs and government-led healthcare reforms are beginning to address gaps in packaging standards and supply chain efficiency. As these regions continue to modernize their healthcare systems and harmonize policies with global standards, the potential for PETG blister market expansion is expected to improve, albeit at a slower pace than in North America and Asia Pacific.

Report Scope